News
Cell TherapiesR&D project spotlight: A collaborative approach to developing a universal ddPCR™ assay to detect residual pluripotent stem cells in cell therapy products
Regulatory News - October 2020Procurement process open for the development of ATSTN National Training CentresOctober newsletter: Driving the clinical adoption of cell and gene therapiesCelebrating the achievements of the Advanced Therapies Apprenticeship CommunityPress Release: CGT Catapult appoints two new Board membersPress Release: Stevenage named High Potential Opportunity zone for Cell and Gene TherapyRegulatory News - September 2020Press Release: CGT Catapult appoints Dr Nick Johnson as Chief Strategy and Impact OfficerPress release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyAdvanced Therapy Treatment Centre network awarded £9.5m further investmentJuly/August news: Large-scale manufacturing innovationRegulatory news - August 2020
